Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B
Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluk...
Saved in:
Published in | Lipids in health and disease Vol. 17; no. 1; pp. 36 - 10 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
05.03.2018
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1476-511X 1476-511X |
DOI | 10.1186/s12944-018-0683-y |
Cover
Loading…
Abstract | Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients.
The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography.
The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism.
The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. |
---|---|
AbstractList | Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. Methods The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. Results The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, [DELA]5 and [DELA]6-desaturase enzymes activities were found lower, while [DELA]9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. Conclusion The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. Keywords: Hypolipidemia, GC-fid, Liver Abstract Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. Methods The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. Results The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. Conclusion The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, [DELA]5 and [DELA]6-desaturase enzymes activities were found lower, while [DELA]9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients.BACKGROUNDHepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients.The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography.METHODSThe fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography.The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism.RESULTSThe hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism.The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation.CONCLUSIONThe serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred in subjects suffering from hepatitis B patients. The fasting blood samples were collected from hepatitis B patients (n = 50) attended in Taluka hospital TandoAdam, Sindh with age and gender matched controls (n = 50). Serum lipid profile and fatty acid (FA) composition were analyzed by micro-lab and gas chromatography. The hepatitis B patients have significantly lower level (p < 0.01) of lipid profile including total cholesterol (TC), triacylglyceride (TAG), high density lipoprotein-C (HDL-C) very low density lipoprotein-cholesterol (VLDL-C), low density lipoprotein-cholesterol (LDL-C), and total lipid (TL) in comparison to controls, indicating hypolipidemia in patients. The result of total FA composition of HBV patients in comparison to controls reveal that myristic, palmitic, docosahexaenoic acids were significantly (p < 0.05) higher, while linoleic, eicosatrienoic, arachidonic, eicosapentaenoic acids were lower in HBV patients in comparison to controls. The elongase, ∆5 and ∆6-desaturase enzymes activities were found lower, while ∆9-desaturase activity was higher in hepatitis B patients as compared to controls, which indicates the impaired lipid metabolism. The serum saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) were increased while polyunsaturated fatty acid (PUFA) was reduced in both total and free form in hepatitis B patients due to altered activities of enzyme desaturases with impaired PUFA metabolism and non-enzymatic oxidation. |
ArticleNumber | 36 |
Audience | Academic |
Author | Talpur, Farah Naz Channa, Naseem Aslam Ali, Muhammad Shahbaz Afridi, Hassan Imran Arain, Sadia Qamar |
Author_xml | – sequence: 1 givenname: Sadia Qamar surname: Arain fullname: Arain, Sadia Qamar – sequence: 2 givenname: Farah Naz surname: Talpur fullname: Talpur, Farah Naz – sequence: 3 givenname: Naseem Aslam surname: Channa fullname: Channa, Naseem Aslam – sequence: 4 givenname: Muhammad Shahbaz surname: Ali fullname: Ali, Muhammad Shahbaz – sequence: 5 givenname: Hassan Imran surname: Afridi fullname: Afridi, Hassan Imran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29506525$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kktv1DAUhSNURB_wA9igSGzYpMRO_NogtRWPSpVYABIrrBvHnnGVsQfbUzT_njuTFnUQKInsnHvup2v5nFZHIQZbVS9Je06I5G8zoarvm5bIpuWya7ZPqhPSC94wQr4fPdofV6c537YtbQXnz6pjqljLGWUn1Y8vNm1W9eTXfsw14BtqH0ZvoMRUO_zK0tYwFZug-Bjq6NB8Z7G2CWav-FCvsWZDyfUvX5b10u7-i8_15fPqqYMp2xf361n17cP7r1efmpvPH6-vLm4awzpaGunAEaIcYa4zjjEnBKBmUGbUuoEIA4rjnkjmiBoUoUxQUASUBNHR7qy6nrljhFu9Tn4FaasjeL0XYlpoSMWbyWpOBPTMMgkj7-3YyWGkrBeO9gMoq0ZkvZtZ682wsqPBgyWYDqCHleCXehHvNJOdlLxDwJt7QIo_NzYXvfLZ2GmCYOMma9oSQoXo5G7u17N1ATiaDy4i0ezs-oL1vJWKU4mu83-48BntyhvMhPOoHzS8enyEP7M_3DsaxGwwKeacrNPGl_0FI9lPmrR6lzA9J0xjwvQuYXqLneSvzgf4_3t-Azgb0_w |
CitedBy_id | crossref_primary_10_1186_s12944_023_01826_y crossref_primary_10_1016_j_cyto_2020_155189 crossref_primary_10_3389_fmicb_2021_636897 crossref_primary_10_1016_j_pdpdt_2022_102808 crossref_primary_10_1186_s12944_025_02434_8 crossref_primary_10_1111_1751_7915_14303 crossref_primary_10_1186_s13104_021_05474_2 crossref_primary_10_1007_s10552_024_01853_9 crossref_primary_10_1016_j_jhep_2022_02_016 crossref_primary_10_1016_j_jprot_2024_105358 crossref_primary_10_1016_j_prostaglandins_2020_106484 crossref_primary_10_1016_j_pdpdt_2021_102386 crossref_primary_10_1016_j_jtumed_2023_01_002 crossref_primary_10_1016_j_jhepr_2022_100479 crossref_primary_10_1021_acs_jproteome_4c00747 crossref_primary_10_1042_BSR20211769 |
Cites_doi | 10.7555/JBR.26.20120058 10.1007/s13197-012-0677-0 10.1111/jgh.12700 10.1002/hep.23229 10.3164/jcbn.12-79 10.1016/j.redox.2016.09.002 10.1016/j.jhep.2010.07.039 10.1074/jbc.M108413200 10.1002/hep.20283 10.1186/1476-511X-12-25 10.1186/s12944-017-0437-2 10.1038/oby.2009.379 10.1146/annurev.physiol.65.092101.142622 10.4062/biomolther.2014.017 10.1016/j.cbpb.2014.06.005 10.1016/B978-012373947-6.00685-1 10.4103/2348-3334.201981 10.1503/cmaj.1030034 10.1111/j.1462-5822.2008.01250.x 10.1111/j.1440-1746.2009.06154.x 10.3748/wjg.v22.i4.1664 10.1074/jbc.M510660200 10.3748/wjg.14.6546 10.1189/jlb.71.1.16 10.1016/S0022-2275(20)31527-3 10.1194/jlr.E033407 10.1194/jlr.M800123-JLR200 10.3390/nu5104093 10.3748/wjg.v20.i33.11595 10.1002/hep.22183 10.5772/51204 10.1097/MD.0000000000003609 10.1093/ijnp/pyx089 10.3390/nu3010152 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 BioMed Central Ltd. The Author(s). 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: The Author(s). 2018 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1186/s12944-018-0683-y |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1476-511X |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_617a45e58ad64ed38bd2547f24ba9e9d PMC5838863 A546089628 29506525 10_1186_s12944_018_0683_y |
Genre | Journal Article |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAHBH AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB NPM PJZUB PPXIY PQGLB PMFND 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c532t-8faf119f15f3cf55f77a8facfaf52efb17ca96f52185f19b912572a91a98a7323 |
IEDL.DBID | M48 |
ISSN | 1476-511X |
IngestDate | Wed Aug 27 01:07:15 EDT 2025 Thu Aug 21 18:15:31 EDT 2025 Fri Jul 11 12:06:33 EDT 2025 Tue Jun 17 21:35:41 EDT 2025 Tue Jun 10 20:14:10 EDT 2025 Mon Jul 21 05:46:45 EDT 2025 Thu Apr 24 22:58:31 EDT 2025 Tue Jul 01 00:23:10 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Hypolipidemia Liver GC-fid |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-8faf119f15f3cf55f77a8facfaf52efb17ca96f52185f19b912572a91a98a7323 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12944-018-0683-y |
PMID | 29506525 |
PQID | 2011277382 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_617a45e58ad64ed38bd2547f24ba9e9d pubmedcentral_primary_oai_pubmedcentral_nih_gov_5838863 proquest_miscellaneous_2011277382 gale_infotracmisc_A546089628 gale_infotracacademiconefile_A546089628 pubmed_primary_29506525 crossref_citationtrail_10_1186_s12944_018_0683_y crossref_primary_10_1186_s12944_018_0683_y |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-05 |
PublicationDateYYYYMMDD | 2018-03-05 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-05 day: 05 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Lipids in health and disease |
PublicationTitleAlternate | Lipids Health Dis |
PublicationYear | 2018 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 683_CR7 683_CR22 C Niederau (683_CR19) 2014; 20 683_CR6 683_CR41 KE Bradbury (683_CR23) 2011; 3 J Araya (683_CR32) 2010; 18 AE Feldstein (683_CR38) 2004; 40 W Wu (683_CR40) 2010; 25 683_CR1 H Miyoshi (683_CR4) 2011; 54 S Ferdinandusse (683_CR35) 2001; 42 X Xue (683_CR26) 2014; 175 CC Wang (683_CR21) 2015; 30 RH Unger (683_CR9) 2003; 65 JK Kwarteng (683_CR5) 2012; 32 N Kaur (683_CR31) 2014; 51 S Noorali (683_CR2) 2008; 2 683_CR33 D Ristic-Medic (683_CR34) 2013; 53 RG Gray (683_CR12) 2013; 12 YA Moon (683_CR24) 2001; 276 P Puri (683_CR25) 2009; 50 CJ Field (683_CR16) 2002; 71 Z Li (683_CR39) 2008; 47 A Agbecha (683_CR18) 2017; 4 BA Conlon (683_CR8) 2013; 5 YA Carpentier (683_CR10) 2008; 22 683_CR30 SQ Arain (683_CR11) 2015; 6 CM Bremer (683_CR15) 2009; 11 KR Feingold (683_CR17) 2012; 53 Y Wang (683_CR27) 2008; 49 M Jiang (683_CR13) 2008; 14 T Sassa (683_CR28) 2014; 22 SQ Arain (683_CR36) 2015; 14 C Ress (683_CR3) 2016; 22 683_CR29 T Wong (683_CR20) 2006; 174 H Malhi (683_CR37) 2006; 281 SQ Arain (683_CR14) 2017; 16 |
References_xml | – ident: 683_CR41 doi: 10.7555/JBR.26.20120058 – volume: 32 start-page: 1 issue: 3 year: 2012 ident: 683_CR5 publication-title: J Sci Technol – volume: 51 start-page: 2289 issue: 10 year: 2014 ident: 683_CR31 publication-title: J Food Sci Technol doi: 10.1007/s13197-012-0677-0 – volume: 30 start-page: 14 issue: 1 year: 2015 ident: 683_CR21 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12700 – volume: 50 start-page: 1827 issue: 6 year: 2009 ident: 683_CR25 publication-title: Hepatol doi: 10.1002/hep.23229 – volume: 53 start-page: 49 issue: 1 year: 2013 ident: 683_CR34 publication-title: J Clin Biochem Nutr doi: 10.3164/jcbn.12-79 – ident: 683_CR7 doi: 10.1016/j.redox.2016.09.002 – volume: 54 start-page: 432 issue: 3 year: 2011 ident: 683_CR4 publication-title: J Hepatol doi: 10.1016/j.jhep.2010.07.039 – volume: 276 start-page: 45358 issue: 48 year: 2001 ident: 683_CR24 publication-title: J Biol Chem doi: 10.1074/jbc.M108413200 – volume: 40 start-page: 185 issue: 1 year: 2004 ident: 683_CR38 publication-title: Hepatol doi: 10.1002/hep.20283 – volume: 12 start-page: 25 issue: 1 year: 2013 ident: 683_CR12 publication-title: Lipids Health Dis doi: 10.1186/1476-511X-12-25 – volume: 16 start-page: 51 issue: 1 year: 2017 ident: 683_CR14 publication-title: Lipids Health Dis doi: 10.1186/s12944-017-0437-2 – volume: 18 start-page: 1460 issue: 7 year: 2010 ident: 683_CR32 publication-title: Obesity doi: 10.1038/oby.2009.379 – volume: 65 start-page: 333 issue: 1 year: 2003 ident: 683_CR9 publication-title: Annu Rev Physiol doi: 10.1146/annurev.physiol.65.092101.142622 – volume: 22 start-page: 83 issue: 2 year: 2014 ident: 683_CR28 publication-title: Biomol Ther doi: 10.4062/biomolther.2014.017 – volume: 175 start-page: 9 year: 2014 ident: 683_CR26 publication-title: Comp Biochem Physiol B: Biochem Mol Biol doi: 10.1016/j.cbpb.2014.06.005 – ident: 683_CR33 doi: 10.1016/B978-012373947-6.00685-1 – volume: 2 start-page: 373 issue: 5 year: 2008 ident: 683_CR2 publication-title: J Infect Dev Ctries – volume: 4 start-page: 81 issue: 2 year: 2017 ident: 683_CR18 publication-title: CHRISMED J Health Res doi: 10.4103/2348-3334.201981 – volume: 174 start-page: 649 issue: 5 year: 2006 ident: 683_CR20 publication-title: CMAJ doi: 10.1503/cmaj.1030034 – ident: 683_CR6 – volume: 11 start-page: 249 issue: 2 year: 2009 ident: 683_CR15 publication-title: Cell Microbiol doi: 10.1111/j.1462-5822.2008.01250.x – volume: 25 start-page: 750 year: 2010 ident: 683_CR40 publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2009.06154.x – volume: 22 start-page: 1664 issue: 4 year: 2016 ident: 683_CR3 publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i4.1664 – volume: 22 start-page: 255 issue: 2 year: 2008 ident: 683_CR10 publication-title: Int J Mol Med – volume: 281 start-page: 12093 issue: 17 year: 2006 ident: 683_CR37 publication-title: J Biol Chem doi: 10.1074/jbc.M510660200 – volume: 14 start-page: 6546 issue: 42 year: 2008 ident: 683_CR13 publication-title: World J Gastroenterol: WJG doi: 10.3748/wjg.14.6546 – volume: 71 start-page: 16 issue: 1 year: 2002 ident: 683_CR16 publication-title: J Leukoc Biol doi: 10.1189/jlb.71.1.16 – volume: 42 start-page: 1987 issue: 12 year: 2001 ident: 683_CR35 publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)31527-3 – volume: 53 start-page: 2487 issue: 12 year: 2012 ident: 683_CR17 publication-title: J Lipid Res doi: 10.1194/jlr.E033407 – volume: 49 start-page: 1538 issue: 7 year: 2008 ident: 683_CR27 publication-title: J Lipid Res doi: 10.1194/jlr.M800123-JLR200 – volume: 5 start-page: 4093 issue: 10 year: 2013 ident: 683_CR8 publication-title: Nutrients doi: 10.3390/nu5104093 – volume: 20 start-page: 11595 issue: 33 year: 2014 ident: 683_CR19 publication-title: WJG doi: 10.3748/wjg.v20.i33.11595 – volume: 14 start-page: 1 issue: 117 year: 2015 ident: 683_CR36 publication-title: BMC Lipids Health Dis – volume: 47 start-page: 1495 year: 2008 ident: 683_CR39 publication-title: Hepatol doi: 10.1002/hep.22183 – ident: 683_CR30 doi: 10.5772/51204 – ident: 683_CR22 doi: 10.1097/MD.0000000000003609 – ident: 683_CR29 doi: 10.1093/ijnp/pyx089 – ident: 683_CR1 – volume: 6 start-page: 37 year: 2015 ident: 683_CR11 publication-title: IJBRR – volume: 3 start-page: 152 issue: 1 year: 2011 ident: 683_CR23 publication-title: Nutrients doi: 10.3390/nu3010152 |
SSID | ssj0020766 |
Score | 2.2844381 |
Snippet | Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that occurred... Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic derangement that... Abstract Background Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. Hence the aim of present study is to determine metabolic... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 36 |
SubjectTerms | Diagnosis GC-fid Health aspects Hepatitis B Hypolipidemia Lipids Liver Liver function tests Methods Physiological aspects |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLaZM-3CZFhdJCwcSSrddxUxpCIT01kFOFJEvEkHhDvHvYf98Z2busKbSXgg-2NAZZM6OZ0Yw_EfLRsRBixWKZ6pqXjTOh9MrzkjlfRalMpT3ud1z9kJfXzfcbcbN31BfWhI3wwOPEnYGFdY2IQrtWNrGttW8hplGJN96ZaFpcfcHmbYOpKdSC6FxOOUym5dkAVq3BaguNh6zU5WZmhTJY_59L8p5NmtdL7hmgi-fk2eQ50sU44hfkSeyPyPGih6j5fkM_0VzLmTfJj8jh1ZQyPya_YDVY39O77qFrB-rg6inmqQNG2xRcVgouIM1J88wkukxADAJO0eTllq6nE_zqQHHflt5GfF51Az1_Sa4vvv38ellOhyqUQdR8VerkEmMmMZHqkIRISjloC9AseEyeqeCMhHsw5IkZb8ADUtwZ5ox2qub1K3LQL_v4hlATqyCdSDHx0HhWuZY5pyrpEEM_BV-QajvJNkyI43jwxZ3NkYeWduSLBb5Y5IvdFOTL7pWHEW7jb8TnyLkdISJl5waQHzvJj_2X_BTkM_Ldoj7D4IKbfkuAT0RkLLsQjay0kVwX5GRGCXoYZt0ftpJjsQuL1_q4XA8WfSyuVK15QV6PkrQbMzcCnEAuCqJmMjb7qHlP391mGHBMeGtZv_0fs_COPOVZO7CY84QcrB7X8RS8rZV_nxXrNyEKKRs priority: 102 providerName: Directory of Open Access Journals |
Title | Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29506525 https://www.proquest.com/docview/2011277382 https://pubmed.ncbi.nlm.nih.gov/PMC5838863 https://doaj.org/article/617a45e58ad64ed38bd2547f24ba9e9d |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA_3AeKL6J0f1XOJIApCtU3bfDyI7Modh7CHiAv7ZEjTxCvsdc_tLrj_vTPZ7rLFU-hDm6SlzcxkZjLT3xDy2qTWuiR1sc8yFudG2bgUJYtTUyaOC5XIEvc7xlf8cpJ_mRbTA7Itb9VNYHuna4f1pCaL2fvfv9afQOA_BoGX_EMLOivHXAqJJVSyeH1IjkExCZTTcb4LKjBw2XkX2LzzNgQGVgXoZKybvaelApj_30v2ns7q51PuKaiLh-RBZ1nS4YYVHpED15yQ02EDXvXNmr6hIdczbKKfkHvjLqR-Sn7AarG6obP6tq5aauBoKMaxLXrjFExaCiYiDUH1QEQ69zAYBICiSgwtdUM7eNaW4r4uvXZ4vaxbOnpMJhfn3z9fxl3RhdgWGVvG0hufpsqnhc-sLwovhIE2C80Fc75MhTWKwzkoep-qUoGFJJhRqVHSiIxlT8hRM2_cM0KVSyw3hXee2bxME1OlxoiEG8TY97aMSLKdZG07RHIsjDHTwTORXG9IpIFEGkmk1xF5t7vldgPH8b_BI6TcbiAiaYeG-eKn7gRTgwVn8sIV0lQ8d1Umywp8ZuFZXhrlVBWRt0h3jRwIL2dN99sCfCIiZ-lhkfNEKs5kRM56I0FOba_71ZZzNHZhclvj5qtWow3GhMgki8jTDSft3nnLkBERPR7rfVS_p6mvA0w4BsQlz57_85kvyH0WuB8zOM_I0XKxci_BxFqWA3IopmJAjkfnV1-_DcJGxSAI0x9omyaZ |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+lipids+as+an+indicator+for+the+alteration+of+liver+function+in+patients+with+hepatitis+B&rft.jtitle=Lipids+in+health+and+disease&rft.au=Arain%2C+Sadia+Qamar&rft.au=Talpur%2C+Farah+Naz&rft.au=Channa%2C+Naseem+Aslam&rft.au=Ali%2C+Muhammad+Shahbaz&rft.date=2018-03-05&rft.eissn=1476-511X&rft.volume=17&rft.issue=1&rft.spage=36&rft_id=info:doi/10.1186%2Fs12944-018-0683-y&rft_id=info%3Apmid%2F29506525&rft.externalDocID=29506525 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |